Inventors: Sandhya Marathe

Utilizing the endogenous CRISPR-Cas system as an anti-pathogen strategy against antimicrobial-resistant enteric pathogens involves enhancing bacterial immunity through genetic engineering. This approach employs CRISPR-Cas systems native to bacteria, enhancing their ability to target and cleave specific DNA sequences of antimicrobial-resistant pathogens.